Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy

Annals of Internal Medicine

Volumn 135, Issue 1, 2001, Pages 27-31

  Yee, A M F ^a   Pochapin, M B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AGED; ARTICLE; CASE REPORT; DIARRHEA; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GRANULOMATOUS INFLAMMATION; HEMODIALYSIS; HUMAN; HYPERCOAGULABILITY; INFLAMMATORY CELL; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; SARCOIDOSIS;

EID: 0035800027     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-1-200107030-00010     Document Type: Article

References (20)

1. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis
2. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers
3. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis
4. Sarcoidosis: Immupathogenetic concepts and their clinical application
5. Sarcoidosis and protein losign enteropathy
6. Protein-losing enteropathy in an unusual form of sarcoidosis
7. Muscle involvement in sarcoidosis. Asympromatic, myositis, and myopathy
8. Increased intestinal permeability in active pulmonary sarcoidosis
9. Bypass enteropathy. Intestinal and systemic manifestations following small-bowel bypass
10. Acute sarcoid myositis with respiratory muscle involvement. Case report and review of the literature
11. Synergistic cytotoxic effect of interferon-gamma and rumor necrosis factor-alpha on cultured human muscle cells
12. Presence of mRNA for interferon-gamma (IFN-gamma) in blood mononuclear cells is associated with an active stage I sarcoidosis
13. Jejunoileal bypass arthrities
14. Sarcoidosis and IFN-alpha treatment
15. Antiphospholipid antibodies. A ptognostic factor in sarcoidosis?
16. Antiphospholipid antibody syndrome in a patient with neurosarcoidosis
17. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy
18. Uncoupling th proinflammatory for mteh immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level. Implications for pathogenesis and therapy of autoimmune demyelination
19. Greatly accelerated lymphadenopathy and automimmune disease in lpr mice lacking tumor necrosis factor receptor I
20. Induction of apoptosis in mature T cells by tumour necrosis factor